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EDITORIAL SUMMARY A protocol for purifying tubulin with controlled posttranslational 
modifications using cycles of polymerisation and depolymerisation. Tubulin can be obtained 
from cultured cells or single mouse brains and used for in vitro reconstitution assays. 
 
TWEET A new protocol for purifying tubulin with controlled posttranslational modifications 
for in vitro reconstitution experiments. 
 
COVER TEASER Purifying tubulin with controlled PTMs 
 
Up to three primary research articles where the protocol has been used and/or 
developed: 
1. Barisic, M. et al. Microtubule detyrosination guides chromosomes during mitosis. Science 
348, 799-803 (2015). 
2. Nirschl, J. J., Magiera, M. M., Lazarus, J. E., Janke, C. & Holzbaur, E. L. F. alpha-Tubulin 
Tyrosination and CLIP-170 Phosphorylation Regulate the Initiation of Dynein-Driven 
Transport in Neurons. Cell Rep 14, 2637-2652 (2016) 
3. Guedes-Dias P, Nirschl JJ, Abreu N, Tokito MK, Janke C, Magiera MM, Holzbaur ELF 
(2019) Kinesin-3 Responds to Local Microtubule Dynamics to Target Synaptic Cargo 
Delivery to the Presynapse. Curr Biol 29: 268-282 e268 
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Abstract 
In vitro reconstitutions of microtubule assemblies have provided essential mechanistic 
insights into the molecular bases of microtubule dynamics and their interactions with 
associated proteins. An emerging regulatory mechanism of microtubule functions is the 
tubulin code, which suggests that tubulin isotypes and posttranslational modifications play 
important roles in controlling microtubule functions. To investigate the mechanism of the 
tubulin code, it is essential to analyse different tubulin variants in vitro. This has so far been 
difficult, as most reconstitution experiments used heavily posttranslationally modified tubulin 
purified from brain tissue. Therefore, we developed a protocol that allows purifying tubulin 
with controlled posttranslational modifications from limited sources using cycles of 
polymerisation and depolymerisation. While alternative protocols using affinity purification 
of tubulin yield very pure tubulin as well, our protocol has the unique advantage to select for 
fully functional tubulin, as non-polymerizable tubulin is excluded in the successive 
polymerisation cycles. It thus provides a novel routine procedure to obtain tubulin with 
controlled posttranslational modifications for in vitro reconstitution experiments. We describe 
specific procedures for tubulin purification from adherent cells, cells grown in suspension 
cultures, or from single mouse brains. The protocol can be combined with drug treatment, 
transfection of cells prior to tubulin purification, or enzymatic treatment during the 
purification process. The amplification of cells and their growth in spinner bottles takes 
approximately 13 days; the tubulin purification itself 6-7 hours. The tubulin can be used in 
TIRF-microscopy-based experiments or pelleting assays to investigate the intrinsic properties 
of microtubules and their interactions with associated proteins.  
 
 
INTRODUCTION 
Microtubules are essential components of the mammalian cytoskeleton, and are important in 
almost all key biological processes, such as cell division, cell motility, or cell differentiation 
(neurons, cilia and flagella, platelets etc.). Owing this importance, one of the key concerns of 
cell biology has been to mechanistically understand how these highly conserved cytoskeletal 
elements adapt to such a huge variety of biological functions. In vitro experiments aiming at 
reconstructing microtubule assemblies and functions from purified tubulin and other 
cytoskeletal components have been instrumental in understanding the biochemical, 
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biophysical and structural properties of microtubules. Tubulin was discovered as the protein 
building block of microtubules in 19671, and soon after, it was shown that tubulin can 
assemble into microtubules in solution2. This led to a plethora of studies on the assembly 
properties and mechanisms of microtubules3,4, on how this assembly was regulated by tubulin 
drugs5 and by microtubule-associated proteins (MAPs)6. In vitro studies with tubulin have 
also allowed to propose the mechanism of microtubule dynamic behaviour, such as 
treadmilling7 and dynamic instability8.  
The development of novel light microscopy techniques9 and the growing availability of 
molecular biology tools for cloning and purifying recombinant proteins led to more and more 
complex in vitro reconstitutions of microtubule assemblies10. This resulted in a large number 
of amazing discoveries based on in vitro reconstitutions of microtubule assemblies, such as 
the self-organisation of microtubules and motor proteins11, the reconstitution of mitotic 
spindle functions in minimal systems12,13, the analysis of cargo transport with isolated 
components14, or the self-repair of microtubules15 to give a few examples.  
The reliability of these experiments strongly depends on the biochemical quality of the 
protein components used for such reconstitution, in particular on high-quality and high-purity 
tubulin. For the past 50 years, virtually all in vitro reconstitutions were performed with 
tubulin purified from brain tissue. Brain tubulin can be obtained in large quantities from cow, 
pig or sheep brain by cycles of warm polymerization and cold depolymerization16. This 
method is highly efficient because of the large abundance of tubulin in brain tissue, and the 
capacity of tubulin to spontaneously polymerize at high protein concentrations. By cycling 
several times between polymerized microtubules (warm) and depolymerized soluble tubulin 
(cold), the method yields highly pure and assembly-competent tubulin, while microtubule 
aggregates or assembly-incompetent soluble tubulin will be eliminated in the consecutive 
cycles. The only “contamination” of such-purified tubulin are microtubule-associated proteins 
(MAPs), which can be removed either by chromatography16, or by the polymerization of 
tubulin in a high-molarity buffer that disrupt the binding of MAPs to the microtubules17.  
The ease of purification of large quantities (gram amounts) of brain tubulin was highly 
convenient, as none of the alternative methods to purify tubulin from other sources could 
reach the quality, quantity and ease of the brain tubulin preparations. Therefore, brain tubulin 
is still today the most-used component for in vitro reconstitutions as well as structural studies. 
This massive use of brain tubulin, however, masks the fact that tubulin is heterogenous in 
different organisms, cells, and even within single cells (e.g. between cytoplasmic and ciliary 
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microtubules18). Both, α- and β-tubulin are expressed from a variety of genes, giving rise to 
tubulin isotypes, which are further subjected to a large variety of posttranslational 
modifications (PTMs). Both, specific isotypes and PTMs mark functionally specialized 
microtubule populations, and might confer specific properties and functions to these 
microtubules. This concept, known as the ‘tubulin code’19, is so far little explored, and one of 
the greatest stumbling stones was the impossibility to purify tubulin with controlled isotypes 
and PTMs that could replace the brain tubulin – a heterogenous mixture of isotypes 
particularly enriched in PTMs – in in vitro assays. While a variety of alternative methods have 
recently emerged, we argue that it will be essential to purify tubulin with controlled PTMs 
using an approach that is highly similar to the established purification of brain tubulin, the 
gold standard in the field.  
The method we describe here allows to purify tubulin from large and medium scale cultures 
of mammalian cells by cycles of polymerization and depolymerization. The quality of such-
purified tubulin is equivalent to brain tubulin, as demonstrated in meticulous in vitro 
reconstitutions20-22. The tubulin prepared from Hela S3 cells has been shown to be virtually 
free of tubulin PTMs, and such nonmodified tubulin can be selectively modified with single 
PTMs20. This is a huge advantage over brain tubulin, which contains an uncontrollable 
mixture of PTMs. Our efforts to downscale the purification procedure has also allowed us to 
set up a small-scale purification of tubulin from single mouse brains (~400 mg vs. ~500 g of a 
cow brain), which has become a complementary tool to study the functions of tubulin from an 
emerging plethora of mouse models with altered tubulin PTMs, isotypes, or with mutations in 
tubulin genes.  
 
OVERVIEW OF THE PROCEDURE 
Our protocol is composed of three main parts. The first part describes the amplification of 
sources from which tubulin will be purified (step 1): cell lines cultured either in spinner 
bottles (step 1.A) or adherently on plastic dishes (step 1.B). It is possible to transfect 
adherently growing cells with expression plasmids, or treat them with drugs (Box 1). We 
further describe how tubulin can be purified from a single mouse brain (step 1.C). 
The second section of the protocol describes the lysis procedures (step 2): the particularities 
of lysis of HEK-293 cells (step 2.A), Hela S3, Hela and U-2 OS cells (step 2.B), or brain 
tissue (step 2.C). 
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The third part describes the tubulin purification process itself (see Fig. 1). First, cells or tissue 
is lysed and the lysate is cleared (steps 3, then 4.A for cell extracts, or 4.B for brain extracts). 
Next, the first polymerisation is performed in low-molarity buffer (steps 7-11), followed by 
the first depolymerisation step (steps 12-17). Optionally, tubulin can then be enzymatically 
treated at this point (step 18). Tubulin is then subjected to the second polymerisation (steps 
19-23), this time in high-molarity buffer to avoid the binding of MAPs to the polymerised 
microtubules, and MAP-free microtubules are subsequently depolymerised (steps 24-30). A 
third cycle of polymerisation (steps 31-35) and depolymerisation (steps 36-41) in low-
molarity buffer can be performed. 
We then describe qualitative and quantitative analysis of the purified tubulin (step 42, Box 2). 
We propose quantification by protein band intensity measurements on Coomassie-stained 
gels, and qualitative analyses using immunoblot with antibodies detecting specific tubulin 
PTMs. 
 
DEVELOPMENT OF THE APPROACH 
When setting up this protocol, one major bottleneck was to polymerise tubulin directly from 
cell extracts. The most important parameter for this to work is the tubulin concentration in the 
initial extract. Tubulin is, with ~25% of the total soluble protein, a major component of brain 
extracts, while it constitutes only ~3% in extracts of cell lines23. To avoid that tubulin does 
not polymerize due to the lower concentration in cell extracts, we modified the first 
polymerization step, which in our protocol is performed at low PIPES molarity. This allows 
MAPs present in the cell extract to help the first round of microtubule polymerization. The 
molarity of PIPES is strongly increased in the second round of polymerisation, in which the 
concentration of tubulin can be adjusted to allow efficient polymerisation at high-molarity 
conditions.  
The first key step of the protocol is the cell lysis, which should assure that most of the cellular 
microtubules depolymerise into soluble tubulin. To ensure this, the procedure is carried out at 
4°C, which promotes microtubule depolymerisation. Secondly, we found that different cell 
types and tissues require different lysis techniques. While HEK-293 cells can be disrupted by 
repetitive pipetting through a narrow pipette tip, Hela S3 cells and other tested cell types need 
a more severe disruption procedure. Large amounts grown in spinner cultures are thus lysed 
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using a French press, or an equivalent cell disrupting apparatus, and small amounts by gentle 
sonication. Brain tissue, in contrast, is best lysed using an Ultra-Turrax® homogeniser. 
An unexpected problem was the difficulty to completely clarify the first extract from lysed 
cells by ultracentrifugation. We encountered substantial problems with a floating layer that 
easily contaminates the clear supernatant, but cannot be avoided by longer centrifugation 
times. We thus chose to carefully remove the clear supernatant between this floating layer and 
the pellet, even if there is some loss of cell extract at this step. We introduced an additional 
low-speed centrifugation step to further clarify the first supernatant. This problem varies 
between different cell types, and can lead to complete failure of the purification procedure if 
too much floating material is included in the first polymerization step. Careful handling is 
therefore of key importance at this first step.  
 
COMPARISON WITH OTHER METHODS 
Compared to its blueprint, the tubulin purification from brain tissue, our method is technically 
more demanding for two reasons: first, the growth of larger amounts of cells needs to be 
established before the method can be started, and second, the lysis step of the cells and first 
clarification of this lysate is more meticulous than it is for brain tissue (see ‘Development of 
the Approach’). Strikingly, a method similar to the here-described has been first used in 1979 
to isolate MAPs specific to Hela microtubules24, but to our knowledge has never been used to 
produce tubulin for in vitro reconstitution approaches. There were also several other 
successful attempts to purify assembly-competent tubulin from different sources in the 
1970ies (reviewed in Farrell, 198225), but none of them has been followed up, perhaps due to 
difficulties in reproducing the cumbersome biochemical procedures.  
Alternative methods to purify tubulin without the need of polymerization-depolymerization 
cycles have also been described. For instance, isotype-specific antibodies were used in 
immuno-affinity purifications to partially separate tubulin into isotype-enriched fractions26. 
Many alternative protocols are based on pre-absorption of tubulin from cell extracts onto 
chromatography columns27,28. All of these methods require chromatography equipment and 
specific expertise, which might be the reason they have not been broadly used.  
Finally, there were two recent developments that have considerably advanced the purification 
of tubulin from sources other than brain tissue: the introduction of the TOG-column and 
purification of recombinant tubulin from insect cells. The TOG column is an affinity matrix 
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based on a domain of the TOG-protein Stu2p from budding yeast. This column uses the 
affinity of tubulin dimers to the TOG-domain to selectively bind tubulin from cell extracts, 
and has been shown to produce highly pure fractions of tubulin from many different tissues or 
cell sources29. The method has so far allowed to purify tubulin from a range of organisms, 
such as yeast or Caenorhabditis elegans, and study the structure30,31 and dynamics32-34 of 
those evolutionarily divergent tubulins, or their impact on the behaviour of motor proteins35.  
One of the most significant recent advances was the development of a method to generate 
recombinant tubulin. This method is based on a bi-cistronic expression of an α- and a 
β-tubulin gene in insect cells using the baculo-virus system. Both genes carry a small epitope 
tag, which allows for a two-step affinity purification of dimers exclusively composed of the 
recombinant α- and β-tubulin36. This method now allows to systematically study the role of 
different tubulin isotypes31,37,38 and tubulin mutations39 in vitro, however, it is a cumbersome 
and time-consuming method to establish and thus only dedicated labs might decide to commit 
to it. 
 
ADVANTAGES, LIMITATIONS AND APPLICATIONS 
The great advantage of the here-described method is the possibility to rapidly produce 
milligram-amounts of pure, assembly-competent tubulin from cell lines. When using spinner 
bottles with Hela S3 cells, the method can be run in the background, and requires only a 
couple of hours per week for cell harvesting and re-inoculation of new spinners, and one day 
per week if tubulin purification is carried out immediately (alternatively, cells can be stored in 
lysis buffer at -80°C, and a larger-scale purification can be performed after collecting several 
rounds of spinner cultures). This tubulin can, in a simple and straight-forward step, be 
converted to detyrosinated tubulin, thus providing already two pure PTM versions20.  
In combination with the overexpression of specific tubulin-modifying enzymes, our approach 
can easily be extended to other tubulin PTMs. Finally, our protocol allows fast and efficient 
purification of tubulin from single mouse brains, which in the light of a growing number of 
transgenic mouse models with altered tubulin PTMs, isotypes, or with tubulin mutations, 
provides great opportunities to study the impact of these alterations directly in vitro.  
A limitation of our system is its restriction to the native tubulin isotype composition of the 
cell line used for the tubulin purification. However, all cell lines analysed so far express rather 
‘generic’ α- and β-tubulin isotypes, i.e. isotypes with the high sequence homologies, which 
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makes such tubulin more homogenous than brain tubulin that is composed of a significant 
amount of the rather divergent β3-tubulin (TUBB3) isotype40. A second limitation of the here-
described method is that specific tubulin isotypes, or tubulins carrying particular PTMs, might 
polymerise less efficiently, or depolymerise less in case they strongly stabilise microtubules. 
They could therefore be lost, or disproportionally reduced during the purification. One 
striking example is polyaminated tubulin, which is completely excluded in the brain tubulin 
purification procedure41. However, we have shown that the currently most-studied tubulin 
modifications, such as acetylation, detyrosination, glutamylation and glycylation, are 
preserved throughout our protocol (see “Anticipated Results”). Thus, while for quantitative 
studies of tubulin modifications or isotype composition the TOG-column should be the 
method of choice29, our protocol is appropriate for meticulous in vitro reconstructions in 
which the high purity and assembly competence of tubulin are key20-22.  
Our method could fully replace the standard brain tubulin preparation, allowing to use tubulin 
free of PTMs and assembled from less divergent tubulin isotypes on a daily basis. A typical 
4-l spinner culture of Hela S3 cells yields ~15 g of cells, which in our hands gives rise to 
~2 mg of tubulin (corresponding to a yield of ~135 µg/g). This is lower than the yield from 
adherent cells, which is rather ~200 µg/g, however, growing cells on plastic dishes is more 
time-consuming, and especially harvesting them from the dishes is more cumbersome. We 
found that ten 15-cm dishes are the maximum number of dishes that can be handled, which 
gives rise to ~1.2 g of cells, yielding ~250 µg of pure tubulin. The lower yield of cells in 
suspension culture could be related to a less complex microtubule cytoskeleton in these 
spherical cells, however this is not a major concern, as spinner cultures are effortlessly grown 
in large quantities. Overall, cycling of tubulin is bound to engender some loss, which is why it 
is not surprising that Widlund et al.29 report three times higher tubulin yields (~460 µg/g) 
from human cells using the TOG-column.  
Finally, our protocol yields ~1 mg/g of tubulin from mouse brains, which is higher as 
compared to the standard yield from pig brain that in our hands is rather ~400 µg/g. This is 
most likely related to the longer post-mortem delay of the pig brains as compared to the 
instantly available mouse brains. Tubulin purified from single mouse brains can be used to 
directly test the in vitro behaviour of microtubules from a growing number of mouse models 
with altered tubulin isotype composition42-44, or tubulin PTMs45,46.  
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EXPERIMENTAL DESIGN 
Upscaling the tubulin production in spinner cultures. While our method also works for 
relatively small amounts of adherently growing cells, spinner cultures to grow cells in 
suspension are primordial in order to obtain milligram-amounts of tubulin. The setup we 
propose here allows growing 4×1 l of suspension cultures in parallel, which yields ~15 ml of 
cell pellet every 7 days, allowing for the purification of ~2 mg of tubulin. We can also purify 
tubulin from two spinner bottles, but not less, as at lower amounts the procedure becomes 
unreliable. Hela S3 cells (ATCC® CCL-2.2™) which have been optimised for growth in 
suspension, do not agglutinate and can thus be grown, harvested and in parallel be re-diluted 
for several weeks or months, without preparing new adherent pre-cultures. Other cells, such 
as HEK-293, have the tendency to form cell aggregates during growth in suspension, which 
makes it necessary to inoculate them each time from an adhered pre-culture, which is more 
time-consuming and work-intense. The advantage of HEK-293 cells is the ease of generating 
stable, inducible cell lines with the Flp-In™ T-REx™ 293 cell line (Thermo Fisher # 
R78007). 
Using a variety of cell and tissue sources to generate custom-modified tubulin. Smaller 
amounts of tubulin can also be purified from adherently growing cells. The advantage of this 
approach is that it allows to use any cell line, treat the cells prior to tubulin isolation, e.g. by 
transfecting expression vectors to express tubulin-modifying enzymes, tubulin isotypes, or to 
treat cells with drugs, all of which would be difficult to impossible in cells growing in 
suspension culture. Another advantage is that specific equipment, such as spinner bottles, is 
not needed. The drawback is that only small amounts of tubulin can be produced (~250 µg for 
ten 15-cm dishes), and that the method is less easily reproducible, as small variations in cell 
numbers, or delays during the cell harvest can have a strong impact on the efficiency of 
tubulin polymerization, and thus on the yield. So far, we successfully prepared tubulin from 
Hela, U-2 OS, and HEK-293 cell lines. Having downscaled the protocol to very small 
volumes, it now obviously allows isolating tubulin from very small amounts of brain tissue, 
i.e. from single brains of transgenic mice. 
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MATERIALS 
 
BIOLOGICAL MATERIALS: 
 
• Hela S3 cells (ATCC® CCL-2.2™)  CRITICAL: Hela S3 cells have been 
specifically selected to be able to grow both as adherent and in suspension cultures.  
CRITICAL: A minimum of one vial of each cell line is necessary to start this 
protocol. ! CAUTION The cell lines used should be regularly checked to ensure that 
they are authentic and are not contaminated with mycoplasma. 
• Flp-In™ T-REx™ 293 cells (Thermo Fisher # R78007) 
• U-2 OS cells (ATCC® HTB-96™) 
• Hela cells (ATCC® CCL-2™) 
• HEK-293 cells (ATCC® CRL-1573™) 
• Mouse brain tissue Mice used here were C57b/6N background, however any mouse 
strain can be used to purify tubulin from brain. Atat1-/- mice lack tubulin acetylation 
and have been described before47. Ttll1-/- mice, lacking one of the major brain tubulin 
polyglutamylases, have been described before45 ! CAUTION Any experiments 
involving mice must conform to relevant Institutional and National regulations. 
Animal care and use for this study were performed in accordance with the 
recommendations of the European Community (2010/63/UE). Experimental 
procedures were specifically approved by the ethics committee of the Institut Curie 
CEEA-IC #118 (authorization no. 04395.03 given by National Authority) in 
compliance with the international guidelines. 
 
REAGENTS: 
 
• PBS (Life Technologies #14190169) 
• DMEM medium (Life Technologies #41965062)  
• Fetal bovine serum (FBS; Sigma #F7524) 
• L-Glutamine (Life Technologies #25030123) 
• Penicillin-Streptomycin (Life Technologies #15140130) 
• Trichostatin A (TSA; Sigma #T8552) 
• jetPEI® (Polyplus #101) 
• Carboxypeptidase A (CPA, Sigma C9268, 1.7 U/µl) 
• EDTA (Euromedex #EU0007-C) 
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• Trypsin (Life Technologies #15090046) 
• PIPES (Sigma #P6757)  CRITICAL We recommend using PIPES from this source 
because of the reproducible quality standard. We once experienced problems with 
PIPES from other suppliers  
• EGTA (Sigma #E3889) 
• 1 M MgCl2 (Sigma #M1028) 
• Phenylmethanesulfonyl fluoride (PMSF; Sigma #P7626) ! CAUTION PMSF 
powder is hazardous. Use skin and eye protection when preparing PMSF solutions. 
• Isopropanol (VWR #20842.298) 
• Aprotinin (Sigma #A1153) 
• Leupeptin (Sigma #L2884) 
• 4-(2-aminoethyl)-benzenesulfonyl fluoride (Sigma #A8456) 
• Triton® X-100 (Sigma #T9284,) 
• 2-mercaptoethanol (Sigma #M3148) ! CAUTION 2-mercaptoethanol is toxic, 
manipulate it under a fume hood 
• GTP (Sigma #G8877)  CRITICAL We recommend using PIPES from this source 
because of the reproducible quality standard. 
• Glycerol (VWR Chemicals #24388.295) 
• KOH (Sigma #P1767) ! CAUTION KOH is corrosive and causes burns; use eye and 
skin protection. 
• Dimethyl sulfoxide (DMSO; Sigma #D8418) ! CAUTION DMSO can enhance cell 
and skin permeability of other compounds. Avoid contact and use skin and eye 
protection. 
• DTT, DL-Dithiothreitol (Sigma #D9779) 
• SDS, Sodium dodecyl sulphate (VWR #442444H) 
• SDS, Sodium dodecyl sulphate (Sigma #L5750)  CRITICAL Only this particular 
SDS reference allows to separate α- and β-tubulin bands. 
• Tris (Trizma® base, Sigma #T1503) 
• HCl Hydrochloric acid (VWR #20252.290) ! CAUTION HCl is corrosive and causes 
burns; use eye and skin protection and work in a chemical fume hood 
• Bromophenol blue (Sigma #1.08122) 
• BSA, Bovine serum albumin (Sigma #A7906) 
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• Liquid nitrogen ! CAUTION liquid nitrogen causes burns; use eye and skin 
protection 
• Ethanol absolute (Fisher Chemical #E/0650DF/15) 
• 40% Acrylamide (Bio-Rad #161-0140) 
• Bis N,N’-Methylene-Bis-Acrylamide (Bio-Rad #161-0201) 
• TEMED, N, N, N′, N′-Tetramethylethylenediamine (Sigma #9281) ! CAUTION 
TEMED is corrosive, toxic and causes burns; use eye and skin protection. 
• APS, Ammonium persulfate (Sigma #A3678) 
• Glycine (Sigma #G8898) 
 
Antibodies 
• Anti-α-tubulin antibody 12G10 (used at 1/500 (vol/vol), Developed by J. Frankel 
and M. Nelson, obtained from the Developmental Studies Hybridoma Bank, 
developed under the auspices of the NICHD, and maintained by the University of 
Iowa) 
• Anti-detyrosinated tubulin antibody (used at 1/1,000 (vol/vol); Merck #AB3201) 
• Anti-tyrosinated tubulin antibody YL1/2 (used at 1/1,000 (vol/vol); Abcam 
#ab6160) 
• Anti-glutamylated tubulin antibody GT335 (used at 1/20,000 (vol/vol); AdipoGen 
#AG-20B-0020) 
• Anti-acetylated tubulin antibody 6-11B-1 (used at 1/2,000 (vol/vol); Sigma #T6793) 
• Anti-polyglutamylated tubulin antibody polyE (used at 1/20,000 (vol/vol); 
AdipoGen # AG-25B-0030) 
• Anti-Mouse HRP-conjugated antibody (used at 1/10,000 (vol/vol); Bethyl #A90-
516P) 
• Anti-Rabbit HRP-conjugated antibody (used at 1/10,000 (vol/vol); Bethyl #A120-
201P) 
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EQUIPMENT: 
 
• 1.5- and 2-ml tubes (Eppendorf® #0030125150 and #0030120094, respectively)  
CRITICAL do not replace original Eppendorf references due to possible differences 
in material 
• 14-ml round-bottom tubes (Falcon #352017) 
• 15-ml screw-cap tubes (Falcon #352095) 
• 50-ml screw-cap tubes (Falcon #352070) 
• Ultracentrifuge tubes appropriate for the rotor used: Beckman #357448 (for TLA-
55); #349622 (for TLA-100.3) and #355631 (for 70.1 Ti) 
• 5-ml, 10-ml, 25-ml sterile pipettes (Corning #4487, #4488 and #4489, respectively) 
• Parafilm (Parafilm® M, Bemis North America, USA) 
• 5-ml, 10-ml, 20-ml syringes without needles (Terumo #SS+05ES1, #SS+10ES1 and 
#SS20ES1, respectively) 
• Micropestles (an alternative method for brain lysis, Eppendorf #0030 120.973)  
• Needles 18G × 1 ½” (1.2 × 38 mm; Terumo #18G) 
• Needles 20G × 1 ½” (0.9 × 38 mm; Terumo #20G) 
• Needles 21G × 4 ¾” (0.8 × 120 mm, B. Braun #466 5643) 
• 15-cm-diameter sterile culture dishes (Corning #430599) 
• Micro-pipettes p2.5, p10, p20, p100, p200 and p1000 and corresponding tips 
• Pipette-boy (Drummond Pipette-Aid® XP) 
• Balance (0.1 – 10 g; Sartorius, CPA64S) 
• pH-meter (Sartorius, Docu-pHmeter) 
• Vortex mixer (Scientific Industries, Inc. #SI-0236) 
• Tabletop centrifuge for 1.5 ml tubes: Eppendorf 5417R (or equivalent) 
• Laboratory centrifuge for 50-ml tubes: Sigma 4-16 K (or equivalent) 
• Cell culture hood 
• Cell culture incubator set at 37°C, 5% CO2 
• Inverted microscope (with fluorescence if cell transfection is to be verified) 
• Biological stirrer Techne MCS-104L installed in the cell culture incubator (for 
spinner cultures) 
• 1-l cell culture vessels, Techne F7610 (for spinner cultures) 
• Beckman Avanti J-26 XP centrifuge (for collecting spinner cultures) 
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• JLA-8.1000 rotor (for collecting spinner cultures) 
• Beckman 1-l polypropylene bottles (for collecting spinner cultures; Beckman 
#355676) 
• Sonicator (Branson Sonifier 450) 
• Blender IKA Ultra-Turrax® (for lysing brain tissue) 
• French pressure cell press (Thermo electron corporation #FA-078A, with a #FA-032 
cell; for lysing big amounts of cells) 
• Ultracentrifuges: Beckman Optima L80-XP (or equivalent), Beckman Optima MAX-
XP (or equivalent) 
• Rotors: Beckman 70.1 Ti; TLA-100.3; and TLA-55 (Beckman #34218, #349481 and 
#366725) 
• Water bath equipped with floaters or tube holders 
• Heating block (Stuart #SBH130D) 
• SDS-PAGE electrophoresis equipment (Bio-Rad #1658001FC) 
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REAGENT SETUP: 
 
Ethanol 70% (vol/vol) Mix 700 ml of absolute ethanol and 300 ml of water. Store at room 
temperature (20°C) and use as long as it is not contaminated. 
Cell culture medium: 1 l DMEM medium supplemented with 10% (vol/vol; 100 ml) FBS, 
200 mM (10 ml) L-Glutamine, and 1× Penicillin-Streptomycin (10 ml). Store at 4°C and use 
as long as it is not contaminated. 
Trichostatin A 10 mM Dissolve 1 mg of TSA in 330.7 µl of DMSO. Store at -20°C for up to 
3 years. ! CAUTION DMSO can enhance cell and skin permeability of other compounds. 
Avoid contact and use skin and eye protection. 
EDTA, 0.5 M pH 8 Dissolve 36.5 g of EDTA in water to a final volume of 250 ml, adjust to 
pH 8.0 with KOH (otherwise EDTA will not dissolve), filter-sterilize or autoclave and store at 
room temperature indefinitely. 
PBS-EDTA, 5 mM Add 5 ml of 0.5 M EDTA to 500 ml of PBS. Filter-sterilize and store at 
4°C for up to 3 years (before each use, visually verify that the solution is not contaminated). 
PBS-EDTA-TSA, 5 µM Add 25 µl of 10 mM TSA to 50 ml of PBS-EDTA. This solution is 
used to detach the cells treated with TSA. It should be prepared freshly prior to use. 
KOH, 10 M Dissolve 140 g of KOH in water to a final volume of 250 ml. Store at room 
temperature indefinitely. 
K-PIPES, 0.5 M pH 6.8 Mix 75.5 g of PIPES with water, followed by adding KOH 
(otherwise PIPES will not dissolve). Adjust to pH 6.8 with KOH; final volume: 500 ml. 
Filter-sterilize or autoclave and store at 4°C for several months. 
K-PIPES, 1 M pH 6.8 Mix 15.1 g of PIPES with water, followed by adding KOH (otherwise 
PIPES will not dissolve). Adjust to pH 6.8 with KOH; final volume: 50 ml. Filter-sterilize or 
autoclave and store at 4°C for several months. 
K-EGTA, 0.5 M, pH 7.7 Dissolve 47.5 g of EGTA in water, adjust to pH 7.7 with KOH; 
final volume: 250 ml. Filter-sterilize and store at room temperature indefinitely.  
 CRITICAL None of the buffers used for the tubulin prep should contain sodium salts, 
always use potassium! 
BRB80 Mix 20 ml of 0.5 M PIPES, 40 µl of 0.5 M K-EGTA and 20 µl of 1 M MgCl2; the 
final composition is: 80 mM K-PIPES pH 6.8; 1 mM K-EGTA; 1 mM MgCl2. Filter-sterilize 
and store at 4°C for several months. 
PMSF, 0.1 M Dissolve 435 mg of PMSF in a final volume of 25 ml of isopropanol. Store 
at -20°C for several months. 
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Protease inhibitors mix (200× concentrated) Dissolve 10 mg of aprotinin, 10 mg of 
leupeptin and 10 mg of 4-(2-aminoethyl)-benzenesulfonyl fluoride in 2.5 ml of water, aliquot 
and store at -20°C for several months. 
Triton X-100, 10% (vol/vol) Mix 5 ml of Triton X-100 with 45 ml of water. Filter-sterilize 
and store at room temperature indefinitely. 
Lysis Buffer Mix 20 ml of BRB80 with 1.5 µl of 2-mercaptoethanol, 200 µl of 0.1 M PMSF, 
100 µl of the protease inhibitors mix (200× concentrated) and, (optional, for HEK-293 cells 
only) 400 µl of 10% (vol/vol) Triton X-100. The final concentrations are: 1 mM 2-
mercaptoethanol, 1 mM PMSF, 1× protease inhibitors mix, (optional, for HEK-293 cells only) 
0.2% Triton X-100 (vol/vol). Lysis buffer should be prepared freshly prior to use. ! 
CAUTION 2-mercaptoethanol is toxic, add it under a fume hood 
GTP, 0.2 M Dissolve 1 g of GTP in 9.5 ml water, adjust to pH 7.5 with KOH. Aliquot and 
store at -20°C for up to 6 months. Avoid repetitive freezing and thawing. 
Tris-HCl, 1 M Dissolve 60.56 g of Tris in 500 ml of water. Adjust the pH to 6.8 with HCl; 
filter-sterilize or autoclave the solution and store it at room temperature indefinitely. 
Laemmli sample buffer, 5× For 40 ml, heat 16 ml of 1 M Tris-HCl pH 6.8, add 4 g of SDS 
(from VWR) and mix gently. Add 2.6 g DTT and 20 ml (or 24 g) of 100% glycerol. Add 
~2.5 mg of Bromophenol blue to obtain the right colour intensity. Final concentrations: 
450 mM DTT, 10% (wt/vol) SDS, 400 µM tris-HCl pH 6.8, 50% (vol/vol) glycerol, ~0.006% 
(wt/vol) bromophenol blue. Aliquot by desired volumes and store indefinitely at -20°C. 
Acrylamide-Bis-acrylamide “TUB” mix Dissolve 2.7 g (0.54%, wt/vol) of Bis-acrylamide 
powder in 500 ml of 40% Acrylamide solution. Stir overnight at 4°C, then store at 4°C for up 
to 6 months. 
SDS “TUB” 20% (wt/vol) For 500 ml, dissolve 100 g of SDS (Sigma #L5750) 500 ml of 
water. Filter sterilize and store at room temperature indefinitely. Heat to 40-50°C if 
precipitate forms. 
Resolving gel “TUB” buffer, 4× For 200 ml, dissolve 36.3 g of Tris in 150 ml of water. 
Adjust the pH to 9.0 with HCl. Add 4 ml of 20% SDS “TUB” (Sigma #L5750) stock solution, 
and make up the volume to 200 ml with water. Final concentrations: 1.5 M Tris pH 9.0, 0.4% 
(vol/vol) SDS (Sigma #L5750). Filter sterilize and store at room temperature indefinitely. 
Stack gel “TUB” buffer, 4× For 100 ml, dissolve 6 g of Tris in 80 ml of water. Adjust the 
pH to 6.8 with HCl. Add 2 ml of 20% SDS (Sigma #L5750) stock and make up the volume to 
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100 ml with water. Final concentrations: 0.5 M Tris pH 6.8, 0.4% (vol/vol) SDS (Sigma 
#L5750). Filter-sterilize and store at room temperature indefinitely. 
SDS-PAGE “TUB”, 10% wt/vol For 10 ml of resolving gel, mix 5 ml of water, 2.5 ml of 
acrylamide-bis-acrylamide “TUB” mix, 2.5 ml of resolving gel “TUB” buffer, 80 µl of 
10% (wt/vol) APS and 10 µl TEMED and pour the gel into an appropriate gel stand. Add no 
more than 300 µl of water on top of the gel and let polymerize undisturbed. For 3 ml of the 
stack gel, mix 1.93 ml of water with 320 µl of acrylamide-bis-acrylamide “TUB” mix, 750 µl 
stack “TUB” buffer, 18.5 µl of 10% (wt/vol) APS and 7.4 µl of TEMED. Remove the water 
from the polymerised resolving gel, add the stack gel mix, insert the appropriate comb 
avoiding air bubbles, and let polymerize undisturbed. Keep at room temperature and use the 
same day. 
SDS-PAGE “TUB” Running buffer 1× For 1 L, dissolve 28.75 g of glycine, 6 g of Tris in 
900 ml of water. Add 5.75 ml of 20% SDS “TUB” (Sigma #L5750), and make up the volume 
to 1 L with water. Store at room temperature for up to 6 months. 
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EQUIPMENT SETUP: 
 
Biological stirrer It should be set inside the cell culture incubator. The rotation speed should 
be 25 rpm for Hela S3 and HEK-293 cells, it should be empirically determined for other cell 
types. 
Blender Set at power 6 or 7. This should be sufficient to lyse the brain tissue by blending 2-3 
times for 10-15 s. 
Sonicator We use the probe of 6.5 mm diameter (Branson #101-148-070), set at “Output 
control” 1, “Duty cycle” 10% and time depending on the cell type used. 
French press We use the French press at medium ratio, and the gauge pressure of 1,000 psi 
(which corresponds to 3,000 psi inside the disruption chamber). 
Ultracentrifuges If two ultracentrifuges are available, one should be set at 4°C, the other at 
30°C. If only one is available, set it first to 4°C and change the temperature to 30°C during 
Steps 7, 19 and 31 and change it back to 4°C during Steps 12, 24 and 36. It is important to 
pre-cool or pre-heat the centrifuge before the run, as this will allow the centrifuge start faster 
for the actual run. 
Ultracentrifuge rotors If two rotors are available, one should be stored at 4°C, the other at 
30°C. If only one is available, pre-cool it first to 4°C and then heat it to 30°C during the 
polymerisation step. In order to efficiently change the rotor temperature, you can put it in a 
watertight plastic bag (to avoid wetting), and put either on ice or in the water bath. The 
temperature of the rotor should always match the temperature of the sample and of the 
centrifugation step, on one hand to keep the sample in optimal conditions (for example to not 
depolymerise microtubules by putting a warm sample into a cold rotor), and on the other hand 
to allow for a faster starting of the centrifuge. 
Water bath Should be set to 30°C. 
Spinner bottle cleaning It is important to keep the spinner vessels clean and dry. We 
recommend the following procedure: 
1. Once the cells are collected from the spinner bottles, immediately fill them with tap 
water, to avoid that remaining cells dry and get stuck to the glass.  
2. As soon as possible, remove the glass ball and wash it. Rinse spinner bottles thoroughly 
with water, using a bottle brush if necessary.  
 CRITICAL STEP Avoid using detergent, as trace amounts of not-rinsed detergent 
could hamper the cell growth during the next culture cycle. 
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3. Re-assemble the spinner with the glass ball, add app. 200 ml (or enough to cover the 
glass ball) of deionised water and autoclave them. 
4. Once autoclaved, under a sterile hood remove water from the spinners. Remove the 
lateral caps completely and open the top cap by tilting it over the edge of the opening. 
Leave in this position in the open hood for a few hours (or overnight) to dry completely. 
 CRITICAL STEP Failure to dry the spinners completely before storing them can 
result in the rusting of the metal screw that holds the glass ball. 
5. Once completely dry, close all the caps, remove from under the hood and store in a 
secure place. 
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PROCEDURE: 
 
Sources of tubulin 
 CRITICAL Throughout this section, the days are numbered relative to the day of cell 
lysis and tubulin purification (day 0). 
1. Grow cells that will be used as sources for isolating tubulin. For growing cells in spinners 
(such as Hela S3 and HEK-293), follow Option A (Fig. 2). For growing adherent cells 
(such as HEK-293, Hela and U-2 OS), follow Option B. When using mouse brain as a 
source, follow Option C. 
 
A. Cells grown in spinners  TIMING ∼10-13 days depending on the number of spinners 
(i) Amplifying the cells (Steps i-iii): Revive the desired cell type in its preferred 
medium. Amplify cells to obtain app. 6×107 cells (day -13). 
(ii) Plate those cells on a minimum of six 15-cm-diameter dishes at ~107 cells per dish. 
Cells from six 80-90% confluent 15-cm plates will be needed to inoculate 2 l of 
suspension culture (two spinners), which is the minimum of cells for a successful 
purification. Prepare enough cells to inoculate the desired number of spinners 
(day -10). 
(iii) Add 1 l of pre-warmed complete medium to each spinner bottle and incubate on the 
stirrer table in the cell culture incubator at 20-25 rpm. This step allows for the 
medium to equilibrate temperature and pH (day -8). 
 CRITICAL STEP To minimize the number of operations, and the risk of 
contaminations, add all supplements for 1 l of complete medium into one of the two 
500-ml DMEM bottles, and add this together with the non-supplemented 500 ml 
DMEM directly into the spinner bottle.  
 CRITICAL STEP In order to avoid bacterial or fungal contaminations, 
thoroughly clean the media bottles and spinner bottles with 70% ethanol before 
transferring them into the cell culture hood. 
 CRITICAL STEP Stir only spinner bottles filled with medium. Stirring empty 
bottles can result in damage. Slightly open the lateral valves of the spinner bottles to 
allow the incubator atmosphere to enter the bottle. 
(iv) Inoculating the spinners (Steps iv-xiii): Remove culture medium from 15-cm plates 
from Step ii with cells at 80-90% confluence (day -7, Fig. 2a). 
(v) Rinse the cells very gently with 5 ml PBS (pre-heated to 37°C) 
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 CRITICAL STEP pipette PBS to the border of the dish, check by eye that cells 
do not detach. 
(vi) Remove all PBS by slightly inclining the culture dish, and removing PBS from the 
border of the dish. 
(vii) Add 2 ml of Trypsin per 15-cm dish, spread it carefully to the entire surface by 
slightly inclining and turning the dish. Incubate for 3 min at 37°C (for Hela S3 cells), 
or at room temperature (for HEK-293 cells). 
(viii) Add 3 ml of warm, complete medium to the plate to arrest trypsin activity, and 
detach cells by pipetting the liquid harshly onto the surface of the dish. Observe the 
detachment of the cell layer by eye. Detach cells from 3 dishes at a time, transfer 
them to a 15-ml conical-bottom tube, and incubate in the cell culture incubator while 
detaching the next lot. 
(ix) Pellet cells at 250×g, room temperature, for 5 min. 
(x) Re-suspend cells obtained from 3 dishes in 5 ml of fresh complete medium, and mix 
them well by pipetting up and down thoroughly to separate the cells, but avoid air 
bubbles. 
 CRITICAL STEP Thorough dissociation of cells at this point is crucial for the 
optimal growth of cells in suspension. It is particularly important for HEK-293 cells, 
which tend to form aggregates. Failure to sufficiently dissociate the cells before 
inoculation can result in larger cell aggregates with cell death inside the aggregates, 
and consequently lead to lower tubulin yields. 
(xi) Add 5 ml of cell suspension to each spinner bottles containing 1 l of pre-equilibrated 
medium under the cell culture hood (Fig. 2a), and return them to the stirrer table in 
the cell culture incubator. 
 CRITICAL STEP Keep the lateral valves of the spinner bottles slightly open. 
(xii) Let cells grow for 1 week, control occasionally for infections or sedimentation due to 
cell aggregation (Fig. 2b,c).  
? TROUBLESHOOTING 
(xiii) (Optional) Treat cells. If stable inducible cell lines are used, or the cells were to be 
treated with drugs, this should be done 48-24 h before harvesting (to be optimized 
for each experiment) (day -2). 
(xiv) Harvesting the cells (Steps xiv-xx): Verify a slightly orange colour of the culture 
medium in the spinner bottles. Check the absence of bacterial contamination of each 
 23
spinner at this point by transferring 0.5 ml of each spinner bottle to one well of a 24-
well dish, and observing the samples with an inverted microscope. 
(xv) Transfer the cell suspension into 1-l centrifuge bottles. This step can be carried out in 
the non-sterile conditions, unless you wish to re-inoculate the spinners straight away 
(applies only for Hela S3 cells, see the Optional step (xvi)). 
(xvi) (Optional) To re-inoculate Hela S3 cells for a new culture, leave approximately 
100 ml of cell suspension in each spinner bottle, and add 1 l of fresh, complete 
medium. Return the spinners to the stirrer table in the incubator. Do not forget to 
keep the lateral valves of the spinner bottles slightly open.  
(xvii) Pellet cells at 250×g, 15 min, room temperature.  
(xviii) Re-suspend cells from one centrifuge bottle in 10 ml of ice-cold PBS, then transfer 
them to the next bottle etc., thus collecting the cells from all the centrifuge bottles 
and transferring them to a 50-ml screw-cap tube on ice. Repeat the rinsing of the 
bottles with 10 ml of PBS once or twice, if there are still cells left in the bottles. Pool 
all the cells in one or two 50 ml tube, fill them to 50 ml with ice-cold PBS if 
necessary. 
(xix) Pellet cells at 250×g, 15 min, at 4°C. Remove the supernatant. 
 CRITICAL STEP During the washing step cell lysis should not occur, but 
microtubules can already start depolymerising inside the cells. This is why we wash 
and pellet the cells at 4°C. 
(xx) Determine the volume of the cell pellet (this should be around 3 ml for a 1-L spinner 
bottle) and add the same volume of the lysis buffer on cells. Re-suspend the cells in 
the lysis buffer. 
 CRITICAL STEP In order to maintain the critical concentration of tubulin in the 
extract, the volume of the lysis buffer should not exceed the volume of the cell pellet. 
 CRITICAL STEP The rest of the protocol refers to a hypothetical cell pellet of 
10 ml (+ 10 ml lysis buffer) but a minimum of 6 ml pellet (2 spinner bottles) is 
sufficient for a successful purification. Please adjust all measures to the real volume 
of your cells in each experiment. 
 PAUSE POINT Once re-suspended in the lysis buffer, cells can be snap-frozen in 
liquid nitrogen, and stored at -80°C for up to two months. 
(xxi) Clean the spinner bottles after use (see Equipment Setup). 
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B. Adherent cells  TIMING ∼5 days 
 CRITICAL Avoid using Hela S3 cells for adherent cell cultures, as their real 
advantage is to be grown in suspension culture. 
(i) Amplifying the cells (Steps i-ii):Revive the desired cell type in its preferred medium. 
Amplify cells to obtain ~108 cells (day -5). 
(ii) Plate all cells on a minimum of ten 15-cm-diameter dishes at ~107 cells per dish. 
Cells from minimum ten 80-90% confluent 15-cm plates will be needed to 
successfully purify tubulin. (day -3) 
(iii) (Optional) Transfect the cells with plasmid DNA using the JetPEI® reagent or treat 
with drugs (see Box 1). 
(iv) Harvesting the cells (Steps iv-xi): Remove the medium from the dishes (done by 
person 1). Remove the medium by sets of three dishes, incline them slightly to 
facilitate soaking all the medium off. 
 CRITICAL STEP A rapid cell harvest is very important for the success of the 
tubulin purification, and should not take more than 15 min for ten 15-cm dishes. For 
optimal results, at least the first time this experiment is carried out, three people 
should participate in this step. Later, one experienced person can handle the rapid 
detachment of cells. 
(v) Rinse the cell monolayer very gently with 7 ml of PBS-EDTA, then aspirate by 
inclining the dishes. 
(vi) Add 5 ml of PBS-EDTA (if cells were treated with TSA (Step 1(B)iii, Box 1), they 
should be detached with PBS-EDTA supplemented with 5 µM TSA [PBS-EDTA-
TSA]), and incubate cells for up to 5 min at room temperature 
 CRITICAL STEP We do not detach cells with trypsin to avoid excessive cell 
lysis during this step. 
(vii) Detach cells from the dishes using a cell lifter (done by person 2). Detach the cells 
by gently shovelling them towards one place on the dish. Detachment of the cell 
monolayer is visible with naked eye. 
? TROUBLESHOOTING 
(viii) Collect the detached cells in a 50-ml screw-cap tube (done by person 3). 
(ix) Rinse each plate with 2 ml of PBS-EDTA (or PBS-EDTA-TSA for cells treated with 
TSA), to collect the remaining cells. 
(x) Pellet the harvested cells at 250×g, 10 min, at 4°C. Remove the supernatant. 
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(xi) Determine the volume of the cell pellet, which for ten dishes should be around 1-
1.5 ml. Add the same volume of the lysis buffer on cells. Re-suspend the cells in the 
lysis buffer.  
 CRITICAL STEP In order to maintain the critical concentration of tubulin in the 
extract, the volume of the lysis buffer should not exceed the volume of the cell pellet. 
 CRITICAL STEP The rest of the protocol refers to a hypothetical cell pellet of 
10 ml (+ 10 ml lysis buffer) but a minimum of ~1 ml pellet (from 10 15-cm dishes) is 
sufficient for a successful purification. Please adjust all measures to the real volume 
of your cells in each experiment. 
 PAUSE POINT Once re-suspended in the lysis buffer, cells can be snap-frozen in 
liquid nitrogen, and stored at -80°C for up to two months. 
 
C. Mouse brain  TIMING ~15 min 
(i) Sacrifice the animal by cervical elongation, open the skull with scissors and extract 
the brain. Wash the brain briefly in the lysis buffer to remove excess blood. 
! CAUTION Animal experimentation is subjected to specific legislation in each 
country, please ensure that you have all necessary permits to work with mice 
 PAUSE POINT It is possible to snap-freeze brains in liquid nitrogen and store 
them at -80°C before proceeding to the lysis. Frozen mouse brains can be stored 
at -80°C for up to 3 years. 
(ii) Add 500 µl of the lysis buffer per adult mouse brain in a round-bottom tube.  
 CRITICAL STEP Round-bottom tubes are essential for a correct 
homogenisation of the brain tissue as the probe is too large to reach the tissue in a 
conical-bottom tube. 
 CRITICAL STEP The rest of the protocol refers to a hypothetical tissue volume 
of 10 ml (+ 10 ml lysis buffer), but a minimum of 1 mouse brain is sufficient for a 
successful purification. Please adjust all measures to the real volume of your cells in 
each experiment. 
 
Cell and tissue lysis  
2. Lyse the harvested cells or tissue. For lysis of HEK-293 cells follow Option A (Fig. 
2). For lysis of Hela S3, Hela and U-2 OS cells, follow Option B. For lysis of brain 
tissue, follow Option C. 
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A. Lysis of HEK-293 cells  TIMING ∼30 min 
(i) Lyse HEK-293 cells by repetitive pipetting up and down through a p1000 tip. 
Depending on the initial volume of cells, either a 5- or 10-ml pipette with a p1000 tip 
stuck on the end (Fig. 3b), or directly a p1000 micropipette should be used. The 
pipetting should be done on ice, for 1 min every 5 min, for 10 min (3 times). 
(ii) Continue pipetting the solution using a p200 tip stuck on the p1000 tip (Fig. 3b) on 
ice, for 1 min every 5 min for 20 min. 
(iii)Take an aliquot of 1/100th volume of the lysis mix (L) for analyses (200 µl for 20 ml 
of L). Add the same volume of Laemmli buffer 2× and boil for 5 min.  
 PAUSE POINT The L sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
B. Lysis of Hela S3, Hela and U-2 OS cells  TIMING ∼30 min  
(i) Lyse Hela S3 cells (from spinner culture) using a French press (set at medium ratio, 
gauge pressure at 1,000 psi), or an equivalent cell lysis equipment. For adherently 
grown cells (Hela, U-2 OS), sonicate cells gently, using the 6.5-mm diameter probe, 
set at “Output control” 1, “Duty cycle” 10% and for around 45 pulses. Sonicate the 
cells in a 14-ml round-bottom tube, which has been cut in height to accommodate the 
probe. 
 CRITICAL STEP The sonication should be gentle, to avoid damaging the 
tubulin, but sufficient to lyse the cells. Check the lysis of the cells every 15 pulses 
(Fig. 3c). 
(ii) Pipette cells through a p200 tip stuck on the p1000 tip (Fig. 3b) on ice, for 1 min 
every 5 min for 10 min. 
(iii) Take an aliquot of 1/100th volume of the lysis mix (L) for analyses (200 µl for 20 ml 
of L). Add the same volume of Laemmli buffer 2× and boil for 5 min.  
 PAUSE POINT The L sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
C. Lysis of brain tissue  TIMING ∼30 min 
(i) Homogenize the brains with an Ultra-Turrax blender equipped with a small, 
∅~5-mm probe. The mix should have the colour and consistency of a strawberry 
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milkshake. Alternatively, homogenize brain tissue using a potter homogenizer or a 
microtube potter, followed by thorough tissue dissociation using rapid pipetting up-
and-down in a 1-ml syringe with a 18G needle. 
(ii) Take an aliquot of 1/100th volume of the lysis mix (L) for analyses (200 µl for 20 ml 
of L). Add the same volume of Laemmli buffer 2× and boil for 5 min.  
 PAUSE POINT The L sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
Lysate clarification  TIMING 40 - 50 min 
3. Clear lysate by centrifugation at 150,000×g, 4°C, 30 min. Choose adequate tubes and 
rotors: Beckman #357448 for volumes up to 1.5 ml (rotor TLA-55), Beckman #349622 
for volumes up to 3.0 ml (rotor TLA-100.3) or Beckman #355631 for volumes up to 
30 ml (rotor 70.1 Ti). Beckman #355631 tubes can be centrifuged half-filled, however, 
for volumes below 10 ml, we recommend using several Beckman #349622 tubes. 
 
4. Remove the supernatant SN1 by following Option A for cell extracts and Option B for 
brain extracts.  
 
A. Cell extracts:  TIMING ∼20 min 
(i) l Remove the supernatant gently and without perturbing the floating layer, using a 
syringe with a needle. For volumes below 4 ml use a 20G needle on a 5-ml syringe, 
for higher volumes use the long, 21G needle on a syringe of appropriate volume.  
 CRITICAL STEP To avoid stirring the solution, remove the supernatant directly 
when taking tubes out of the centrifuge (instead of carrying them to the bench or 
placing them in an ice box).  
(ii) Enter the needle into the supernatant and slowly soak off the liquid by gently moving 
the needle tip down toward the pellet. As soon as you observe soaking of the floating 
layer into the syringe, stop. It is important to remove all supernatant at once; going 
back and forth with the needle leads to rapid contamination of the clear supernatant.  
(iii) Record the volume of SN1. For a 10-ml cell pellet, SN1 should be ~12 ml. 
 CRITICAL STEP Removing clear supernatant is straightforward for brain 
lysates, from which solid pellets are obtained. It is more difficult for cell extracts, 
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which yield very unsteady pellets, and a floating instable layer of material on the top 
of the supernatant. This material should not be transferred to the next step, as it tends 
to interfere with the efficiency of tubulin polymerisation.  
(iv) (Optional) If despite your efforts, the supernatant is cloudy, transfer it to a 15- or 
50-ml tube and centrifuge at 5,000×g, 4°C for 10 min (Fig. 3d). 
 
B. Brain extracts:  TIMING ∼10 min 
(i) Place the tubes on ice. Remove the supernatant (SN1) with a micropipette of the 
right volume.  
(ii) (Optional) If the supernatant is cloudy, transfer it to a 15- or 50-ml tube and 
centrifuge at 5,000×g, 4°C for 10 min (Fig. 3d). 
 
5. Take an aliquot of 1/100th volume of the SN1for analyses (120 µl for 12 ml of SN1). 
Add the same volume of Laemmli buffer 2× and boil for 5 min.  
 PAUSE POINT The SN1 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see Box 2). 
 PAUSE POINT 
 CRITICAL STEP Do not freeze the clarified lysates. Proceed at least until step 10. 
 
6. Resuspend the pellet P1 in BRB80 (use the same volume as SN1), and keep an aliquot 
of 1/100th of its volume (∼200 µl for ∼20 ml of P1) for analyses. Add the same volume 
of Laemmli buffer 2× and boil for 5 min. Discard the remaining P1. 
 PAUSE POINT The P1 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
First polymerisation in low-molarity buffer  TIMING ∼1 h 
7. Prepare the polymerization mix in a screw-cap tube of appropriate volume at room 
temperature:  
- 1 volume SN1 (12 ml) 
- 1/200th volume 0.2-M GTP (60 µl), final concentration 1 mM 
- 0.5 volume glycerol (6 ml), pre-heated to 30°C (glycerol volume is not considered in 
calculations, as it is used as a crowding agent). 
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8. Mix well, avoiding air bubbles, and transfer to one or several room temperature 
ultracentrifuge tubes of the appropriate volume. Equilibrate the weight of tubes in the 
process (in pairs). 
 CRITICAL STEP Proceeding to the polymerisation step directly in centrifuge tubes 
equilibrated for centrifugation avoids the risk of depolymerising microtubules when 
pipetting the solution after polymerisation. 
 
9. Cover the tubes with parafilm and transfer them to a 30°C water bath. Let polymerise 
for 20 min.  
 CRITICAL STEP In our hands, the efficiency of polymerisation is equivalent at 
30°C and 37°C, which is why we opted for 30°C. We restricted the polymerisation time 
to 20 min (max. 30 min), as longer incubation did not increase yields.  
 
10. Spin down polymerised microtubules at 150,000×g, at 30°C, for 30 min. The pellet P2 
(Fig. 3d) contains polymerised microtubules with associated MAPs, as well as other 
precipitated proteins. The supernatant SN2 contains non-polymerised tubulin and other 
soluble proteins which do not bind microtubules. 
 PAUSE POINT The microtubule pellet can be snap-frozen in liquid nitrogen and 
stored at -80°C for up to 1 year. 
? TROUBLESHOOTING 
 
11. Take an aliquot of 1/200th of the SN2 for analyses (90 µl for 18 ml of SN2). Add 90 µl 
of Laemmli buffer 2× and boil for 5 min. The remaining SN2 can be discarded. 
 PAUSE POINT The SN2 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
First depolymerisation  TIMING ∼1 h 
12. Transfer the tube with the microtubule pellet P2 on ice, and add 1/60th (= 200 µl, for 
tubulin from cells) or 1/20th (= 600 µl, for tubulin from brains) volume of SN1 (=12 ml) 
of ice-cold BRB80, leave on ice for 5 min. 
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13. Pipette vigorously up and down with a p1000 micropipette to resuspend and 
depolymerise microtubules. Avoid air bubbles. (Fig. 3d) 
 
14. Continue pipetting up and down with a p200 micropipette until the suspension is 
homogenous. Leave on ice for 20-30 min, pipet up and down every 5 min. 
 CRITICAL STEP The high efficiency of this step is fundamental for the overall 
yield of the tubulin purification. Give it time and patience it needs.  
 
15. Transfer the tubulin-MAP solution to a cold 1.5-ml Beckman #357448 tube. Spin down 
insoluble components at 150,000×g, 4°C for 20 min. The supernatant SN3 (~200 µl) 
contains the depolymerised tubulin, MAPs and potentially other soluble proteins. The 
pellet (P3) contains non-depolymerised microtubules, MAPs, and precipitated proteins.  
 
16. Transfer SN3 to a new 1.5-ml conical tube on ice. Take an aliquot of 1-4 µl of the SN3 
for analyses. Add 9 volumes of Laemmli buffer 2× and boil for 5 min. 
 PAUSE POINT The SN3 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 PAUSE POINT 
 CRITICAL STEP Do not freeze the SN3. Proceed at least until step 22. 
 
17. Resuspend the pellet P3 in BRB80 (use the same volume as SN3), and keep an aliquot 
of 1-4 µl for analyses. Add 9 volumes of Laemmli buffer 2× and boil for 5 min. The rest 
of P3 can be discarded. 
 PAUSE POINT The P3 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
(Optional) Enzymatic treatment of the tubulin  TIMING 10 min - 1 h 
18. Incubate SN3 (200 µl) with 1/500th (vol/vol; 0.4 µl ≈ 0.7 U) of Carboxypeptidase A 
(CPA) for 5 min at 30°C in order to obtain entirely detyrosinated tubulin. 
 PAUSE POINT 
 CRITICAL STEP Do not freeze the SN3. Proceed at least until step 22. 
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Second polymerisation in high-molarity buffer  TIMING ∼1 h 
19. Prepare the high-molarity polymerization mix in a 1.5-ml Beckman #357448 tube at 
room temperature: 
- 1 volume SN3 (200 µl) 
- 1 volume 1 M PIPES (200 µl), (pre-heated to 30°C), final concentration 0.5 M 
- 1/100th volume 0.2 M GTP (2 µl), final concentration 1 mM 
- 1 volume glycerol (200 µl), pre-heated to 30°C (glycerol volume is not considered in 
calculations, as it is used as a crowding agent) 
 
20. Mix well, avoiding air bubbles, and transfer to one or several room-temperature 1.5-ml 
Beckman #357448 ultracentrifuge tubes. Pipette precise volumes for rotor equilibration.  
 CRITICAL STEP Proceeding to the polymerisation step directly in centrifuge tubes 
of equilibrated weight avoids the risk of depolymerising microtubules when pipetting 
the solution after polymerisation. 
 
21. Polymerize for 20 min in a 30°C water bath.  
 CRITICAL STEP In our hands, the efficiency of polymerisation is equivalent at 
30°C and 37°C, which is why we opted for 30°C. We restricted the polymerisation time 
to 20 min (max. 30 min), as longer incubation did not increase yields. 
 
22. Sediment polymerised microtubules at 150,000×g, 30°C for 30 min. The pellet P4 
contains polymerised microtubules. The supernatant SN4 contains the MAPs, and small 
amounts of non-polymerised tubulin and other soluble proteins (Fig. 3d). 
 PAUSE POINT The microtubule pellet can be snap-frozen in liquid nitrogen and 
stored at -80°C for up to 1 year. 
 CRITICAL STEP Remove the supernatant very carefully, in order to eliminate a 
maximum of MAPs from the microtubule pellet. Note that with each polymerisation 
cycle the amount of non-polymerising tubulin, as well as non-depolymerisable 
microtubules decreases. 
 PAUSE POINT For further use of MAPs, SN4 can be snap-frozen in liquid nitrogen 
and stored at -80°C for up to 3 years. As MAPs are in the polymerisation buffer 
containing high PIPES and glycerol, a buffer exchange is required before further use. 
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? TROUBLESHOOTING 
 
23. Take an aliquot of 1-4 µl of the SN4 for analyses. Add 9 volumes of Laemmli buffer 2× 
and boil for 5 min.  
 PAUSE POINT The SN4 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
Second de-polymerisation  TIMING ∼50 min 
24. Transfer the tube with the microtubule pellet P4 on ice, and add 1/100th (= 120 µl, for 
tubulin from cells) or 1/40th (= 300 µl, for tubulin from brains) of the volume of SN1 
(= 12 ml) of ice-cold BRB80 on the microtubule pellet P4, leave on ice for 5 min. 
 
25. To resuspend and depolymerise microtubules, pipette up and down with a p200 
micropipette. Avoid air bubbles.  
 
26. Continue until the suspension is homogenous. Leave on ice for 20 min, pipet up and 
down every 5 min. 
 
27. Transfer the tubulin solution to a cold 1.5-ml Beckman #357448 tube. Spin down 
insoluble components at 150,000×g, 4°C for 20 min. 
 
28. The supernatant SN5 contains almost exclusively depolymerised tubulin. The pellet P5 
(Fig. 3d) contains non-depolymerised microtubules. Transfer SN5 to a new 1.5-ml 
conical tube on ice. 
 
29. Take an aliquot of 1-4 µl of the SN5 for analyses. Add 9 volumes of Laemmli buffer 2× 
and boil for 5 min. 
 PAUSE POINT The SN5 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 PAUSE POINT 
 CRITICAL STEP Do not freeze the SN5. Proceed at least until step 34. 
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30. Resuspend the pellet P5 in BRB80 (use the same volume as SN5), and keep an aliquot 
of 1-4 µl for analyses. Add 9 volumes of Laemmli buffer 2× and boil for 5 min. The rest 
of P5 can be discarded. 
 PAUSE POINT The P5 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
Third polymerisation in low-molarity buffer and warm spin  TIMING ∼1 h 
 CRITICAL The third polymerisation-depolymerisation cycle (Steps 31-43) can also be 
performed directly before the use of the tubulin for the actual in vitro experiments. 
31. Prepare the polymerization mix in a 1.5-ml Beckman #357448 tube at room 
temperature:  
- 1 volume SN5 (120 µl) 
- 1/200th volume 0.2 M GTP (0.6 µl), final concentration 1 mM 
- 0.5 volume glycerol (60 µl), pre-heated to 30°C 
 
32. Mix well, avoiding air bubbles, and transfer to one or several room-temperature 1.5-ml 
Beckman #357448 ultracentrifuge tubes. Pipette precise volumes for rotor equilibration.  
 CRITICAL STEP Proceeding to the polymerisation step directly in centrifuge tubes 
of equilibrated weight avoids the risk of depolymerising microtubules when pipetting 
the solution after polymerisation. 
 
33. Polymerize for 20 min in a 30°C water bath.  
 CRITICAL STEP In our hands, the efficiency of polymerisation is equivalent at 
30°C and 37°C, which is why we opted for 30°C. We restricted the polymerisation time 
to 20 min (max. 30 min), as longer incubation did not increase yields. 
 
34. Sediment polymerised microtubules at 150,000×g, 30°C for 30 min. The pellet P6 
contains polymerised microtubules. The supernatant SN6 contains small amounts of 
non-polymerised tubulin. 
 PAUSE POINT The microtubule pellet can be snap-frozen in liquid nitrogen and 
stored at -80°C for up to 1 year. 
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35. Take an aliquot of 1-4 µl of the SN6 for analyses. Add 9 volumes of Laemmli buffer 2× 
and boil for 5 min. The rest of SN6 can be discarded. 
 PAUSE POINT The SN6 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
Third depolymerisation  TIMING ∼50 min 
36.  Transfer the tube with the microtubule pellet P6 on ice, and add 1/100th (= 120 µl, for 
tubulin from cells) or 1/40th (= 300 µl, for tubulin from brains) of the volume of SN1 
(= 12 ml) of ice-cold BRB80 on the microtubule pellet P6, leave on ice for 5 min. 
 
37. Pipette vigorously up and down with a p200 micropipette to resuspend and 
depolymerise microtubules. Avoid air bubbles. 
 
38. Continue pipetting up and down with a p20 pipette until the suspension is homogenous. 
Leave on ice for 20-30 min, pipet up and down every 5 min. 
 
39. Transfer the tubulin solution to a cold 1.5-ml Beckman #357448 tube. Spin down 
insoluble components at 150,000×g, 4°C for 20 min. The supernatant SN7 contains 
pure, depolymerised tubulin. The pellet P7 contains non-depolymerised microtubules. 
Transfer SN7 to a new 1.5-ml conical tube on ice. 
 
40. Take an aliquot of 1-4 µl of the SN7 for analyses. Add 9 volumes of Laemmli buffer 2× 
and boil for 5 min.  
 PAUSE POINT The SN7 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
41. Resuspend the pellet P7 in BRB80 (use the same volume as SN7), and keep an aliquot 
of 1-4 µl for analyses. Add 9 volumes of Laemmli buffer 2× and boil for 5 min. The rest 
of P7 can be discarded. 
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 PAUSE POINT The P7 sample can be stored at -20°C for up to 1 year. Once all 
samples are collected, the quality of the purification is determined in Step 42 (see 
Box 2). 
 
42. Quantify protein content of SN7 (see Box 2 for more details).  TIMING 10 min – 3 h 
 
43. Aliquot SN7 into small volumes to avoid future thaw-freeze cycles, snap-freeze in 
liquid nitrogen and store at -80°C.  TIMING 10 – 30 min 
 PAUSE POINT Purified tubulin samples can be stored at -80°C until needed. We 
have not observed any decrease in polymerisation-activity after storing for up to 
5 years. 
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Box 1: Transfection and drug treatment of adherently growing cells. TIMING: 1-4h 
 
Transfection with plasmid DNA using the JetPEI® reagent 
(note that Hela S3 cells are very difficult to transfect using the here-described protocol) 
1. Seed cells the day before the transfection, so that they are at ~75% confluence. 
2. Mix the JetPEI reagent gently by inverting the tube. For each 15-cm dish, dilute 50 µl of 
jet PEI in 450 µl of plain DMEM medium (without any supplement). Prepare the total 
volume needed depending on the number of dishes (500 µl of JetPEI in 4.5 ml of 
DMEM if 10 dishes are used).  
3. Mix well, spin shortly to collect the whole volume at the bottom of the tube, and leave 
under the hood for 5 min.  
4. Dilute 25 µg of plasmid DNA in 500 µl of plain DMEM per one dish. Prepare the total 
volume needed for all dishes (250 µg of DNA in 5 ml of DMEM for 10 dishes).  
5. Add the diluted jetPEI into the diluted DNA and vortex vigorously for 15 s. Leave 
under the hood for 15-30 min before transfection, without exceeding 30 min. 
 CRITICAL STEP Always add the diluted jetPEI into diluted DNA, and not the other 
way around. Strictly observe vortexing time. This is essential to form transfection-
efficient DNA-jetPEI complexes. 
6. During the 15-min waiting time, replace the complete medium of the cells with the fresh, 
pre-heated medium.  
7. Gently tap the DNA-jetPEI mix from step 5 and add 1 ml of it dropwise onto each dish. 
Mix by swirling gently and return to the incubator. 
 
Drug treatment  
1. Prepare the drug at the right dilution. For trichostatin A (TSA), an inhibitor of the tubulin 
deacetylase HDAC648,49, add 1.2 µl of 10 mM TSA to 12 ml of fresh medium, per dish 
(final concentration of 1 µM). Prepare enough TSA depending on the number of dishes 
(12 µl of 10 mM TSA in 120 ml of medium if 10 dishes are used). 
2. Leave the drug on the cells for the desired time, depending on the drug. For trichostatin A 
(TSA), cells are exposed to the drug for 4 h in the cell culture incubator prior to cell 
harvest. 
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Box 2: Analysis of the obtained tubulin. TIMING: 10 min – 3 h 
 
The enrichment of tubulin can be followed throughout the purification procedure using a 
Coomassie-stained SDS-PAGE gel (Step 2). We also suggest quantifying obtained tubulin on 
an SDS-PAGE gel (Step 3), because in our hands, spectrometry methods do not give a good 
reading of the tubulin concentration. The tubulin sample can be further analysed for the 
presence of expected tubulin isotypes or PTMs by immunoblotting (Step 4). We recommend 
using the custom-made “TUB” gels, which allow the separation of α- and β-tubulins50 (see 
Reagent Setup section). 
 
Procedure: 
1. Analysis sample preparation 
The volume of the sample collected from each step of the main procedure, but especially 
from the latest steps, where the volume of the sample can be very limited, depends on the 
extent of analysis needed (see Table below). If only purification success (Step 2) and 
quantification (Step 3) are envisaged, a 1-µl sample from each of these steps is sufficient. 
In case immunoblot analysis (Step 4) is necessary, it is useful to collect up to 4 µl of the 
solution, giving the possibility to run several SDS-PAGE gels. Add the same volume of 2x 
Laemmli sample buffer to each sample and boil the sample for 5 min. 
 PAUSE POINT The samples can be stored at -20°C for up to 3 years 
Fraction  Sample Loading 
Fraction 
name 
Total 
fraction 
volume 
Amount 
(part) 
collected 
Volume 
collected 
Volume 
of 2x 
Laemmli 
sample 
buffer 
added 
Further 
dilution 
in 2x 
Laemmli 
sample 
buffer 
Volume of the 
fraction to be 
loaded 
(1/2,400th of 
the total 
fraction 
volume) 
Volume of the 
sample to load 
on the gel 
L, P1 20 ml 1/100th  200 µl 200 µl - 8.33 µl 16.67 µl 
SN1 12 ml 1/100th  120 µl 120 µl - 5 µl 10 µl 
SN2 18 ml 1/200th 90 µl 90 µl - 7,5 µl 15 µl 
P2, SN3, P3 200 µl 1/200th or 
1/50th 
1 or 4 µl 9 or 36 µl 10x 0.083 µl 8.3 µl  
SN4 600 µl 1/600th 
or 1/150th 
1 or 4 µl 9 or 36 µl 10x 0.25 µl 25 µl 
SN6 180 µl 1/180th or 1 or 4 µl 9 or 36 µl 10x 0.075 µl 7.5 µl 
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1/45th  
P4, SN5, P5, 
P6, SN7, P7 
120 µl 1/120th or 
1/30th 
1 or 4 µl 9 or 36 µl 10x 0.05 µl 5 µl  
 
2. Tubulin purification quality test 
To verify the success and purity of the tubulin purified using this protocol, we use 
Coomassie-stained SDS-PAGE gels allowing to separate α- and β-tubulins and which have 
been described previousely50 (see Reagent Setup section). Load an equal fraction of each 
sample from the purification steps (see Table above) to assess the enrichment of tubulin 
(Fig. 4a). 
3. Quantification of the tubulin 
We quantify the tubulin using standardised BSA samples. Load two quantities of the 
tubulin sample (for example 0.05 µl and 0.1 µl of the SN7) on an SDS-PAGE gel next to a 
range of different, known quantities of BSA protein (0.5 µg – 1 µg – 2 µg - 3 µg). After 
staining the gel with Coomassie brilliant blue and scanning it, deduce the concentrations of 
α- and β-tubulins in your sample using the linear regression of the BSA-band intensities. If 
using the “TUB” SDS-PAGE gels, note that α- and β-tubulins will have to be quantified 
separately. 
 CRITICAL STEP Make sure the scanner is set to a linear range, and do not 
manipulate the contrast setting to allow a correct determination of relative intensities of the 
analysed bands. 
4. Analysis of obtained tubulin by immunoblot (Fig. 4b-d) 
In order to confirm the presence of desired tubulin PTMs, we recommend immunoblot 
analysis. Based on the quantification of the purified tubulin, load between 0.1 – 0.2 µg of 
tubulin on a “TUB” SDS-PAGE gel (allowing to separate α- and β-tubulins50, see Reagent 
Setup section). As the antibodies towards tubulin PTMs are very specific and give strong 
signals already at low tubulin concentrations, it is crucial to load a small amount of the 
tubulin sample. We also avoid incubating the membranes with the antibodies for more than 
2 h at room temperature. Always check the equal loading of your samples by performing 
an immunoblot with a PTM-independent anti-α-tubulin antibody (12G10) and include a 
positive control, for example brain tubulin. 
? TROUBLESHOOTING 
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TIMING 
 
Step 1, preparing tubulin source 
Option A, cells grown in spinners: 10-13 days 
Steps 1A(i-iii), cell amplification (on plates): 3-6 days 
Steps 1A(iv-xi), inoculation of spinners: ∼2 h 
Step 1A(xii) cell growth in spinners: 7 days 
Step 1A(xiii) (optional) cell treatment: ∼20 min 
Steps 1A(xiv-xx), harvesting cells: ∼90 min 
Option B, adherent cells: 5-6 days 
Steps 1B(i-ii), cell amplification: 5-6 days 
Step 1B(iii) Box 1, treatment of cells: 1-4 h 
Steps 1B(iv-xi), harvesting cells: ∼1 h 
Option C, mouse brain: 15 min (not considering the time necessary to breed the donor 
mouse) 
Step 2, lysis 
Option A, HEK-293 cells: ∼30 min 
Option B, Hela S3 cells: ∼30 min 
Option C, mouse brain: ∼30 min 
Step 3-6, lysate clarification: 40-50 min 
Option A, ell extracts: ∼50 min 
Option B, brain extracts ∼40 min 
Steps 7-11, first polymerisation and warm spin: ∼1 h 
Steps 12-17, first de-polymerisation and cold spin: ∼1 h 
Step 18, (optional) enzymatic treatment: 10 min – 1 h  
Steps 19-23, second polymerisation and warm spin: ∼1 h 
Steps 24-30, second de-polymerisation and cold spin: ∼50 min 
Steps 31-35, third polymerisation and warm spin: ∼1 h 
Steps 36-41, third de-polymerisation and cold spin: ∼50 min 
Step 42, Box 2, quantification of obtained tubulin: 10 min – 3 h 
Step 43, aliquoting and snap freezing: 10-30 min 
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TROUBLESHOOTING 
 
Troubleshooting guidance can be found in Table 1. 
 
Table 1. Troubleshooting Table 
step problem Possible reason Possible solution 
1A(xii) 
Large cell 
aggregates 
(Fig. 2b,c) 
Too low rotation speed in spinner 
cultures  Increase the speed of rod rotation 
Lack of cell growth Closed lateral spinner flask caps Open the lateral caps slightly (half a turn) to allow air exchange 
Bacterial or fungal 
contamination 
Contamination carried inside the 
cell culture hood via media or 
spinner bottles 
Clean all bottles with 70% ethanol 
before transferring them under the 
hood 
Manipulation (transfer between 
the bottle and the spinner flasks) 
of large quantities of media 
Manipulate media with more care; 
avoid spilling the medium 
1B(vi) 
Lysis of cells 
during detachment 
from plastic dishes 
Too brutal treatment of cells 
Collect the cells by gently 
lifting/shovelling them to one side 
of the dish 
Too slow detachment of cells 
Prepare all the necessary material 
in forehand and ask two colleagues 
for help with this part of the 
procedure 
10 
Large pellet after 
1st polymerisation, 
but devoid of 
tubulin 
Insufficient clearing of the lysate 
in step 4B(iii) 
Collect only clear supernatant in 
step 4. Further clarify the 
supernatant by centrifugation in 
step 4B(iii). 
No microtubule 
pellet after 1st 
polymerisation 
Insufficient tubulin concentration 
due to incomplete lysis in step 2 
Verify the lysis of the cells and 
extend incubation time at 4°C prior 
to clarification in step 2 
Incorrect cell treatment prior to 
lysis in step 1B(vi) 
Speed up cell collection procedure 
and avoid breaking the cells before 
the lysis step 1B(vi) 
Insufficient tubulin concentration 
in the cell extract 
Lysis buffer volume should not 
exceed the volume of the cell pellet 
in steps 1A(xx); 1B(x) 
Hydrolysed GTP Use a fresh aliquot of GTP 
Reaction carried out at wrong 
temperature 
Check the temperature of the water-
bath with a thermometer 
22 
No microtubule 
pellet after 2nd 
polymerisation 
Insufficient tubulin concentration 
after 1st depolymerisation 
Depolymerise tubulin in lower 
volume in step 12 
Incomplete tubulin de-
polymerisation in steps 12-14 
Repeat the depolymerisation 
procedure in steps 12-15 on the 
pellet P3 from step 15 
Box 2 
Step 4 
Lack of expected 
modification on 
purified tubulin 
Failed transfection of cells or drug 
treatment 
Use freshly thawed cells, check the 
quality of plasmid DNA, adapt drug 
treatment protocol 
Overloading of the SDS-PAGE Dilute the sample to load 0.2-
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gel with the sample 0.5 µg of tubulin 
 
 
ANTICIPATED RESULTS 
The key application of the here-described tubulin purification protocol are advanced in vitro 
reconstitutions of microtubule assemblies using tubulin purified from cell lines or mouse 
brains with controlled tubulin PTMs. The rationale of our approach was to adapt the method 
considered the gold standard for tubulin purification; the repeated polymerisation and 
depolymerisation of brain tubulin, to purify tubulin from other sources. Using our protocol, 
we obtain reproducible high-quality, highly pure tubulin (Fig. 4a). Due to the relatively small 
sample sizes (as compared to the previously used brain-tubulin purification), our protocol 
shows some variations in yield, but never in quality.  
If initially posttranslationally modified, the tubulin purified by our protocol maintains all of 
the commonly studied PTMs (Fig. 4b-d), and can therefore be used to compare differentially 
modified microtubules side-by-side20,21. However, it should be kept in mind, and eventually 
tested, that the repeated polymerisation and depolymerisation cycles could bias the 
composition of the final tubulin. For quantitative analyses of the tubulin composition in cells 
and tissues, the method by Widlund et al.29 should be used.  
The quantities of tubulin obtained by our protocol are sufficient for a wide range of 
applications. Using a set of four spinner bottles that are maintained continuously, which is 
possible with Hela S3 cells that can be constantly diluted without adherent pre-cultures, a 
laboratory can produce ~2 mg of tubulin per week with a work input of about one day for the 
tubulin purification. This work load could be even further reduced by collecting cells at -80°C 
and for a larger-scale tubulin purification. For most TIRF-microscopy based assays, only µg-
amounts of tubulin are needed, thus, the PTM-free Hela S3 tubulin produced by this protocol 
could fully replace brain tubulin for an entire research team. Even classic microtubule co-
sedimentation assays, though more tubulin-consuming, require ~100 µg of pure tubulin for 
one dilution series51,52, and can thus easily be performed with tubulin purified with our 
protocol.  
The yield of tubulin from single mouse brains is also sufficient to perform virtually all known 
in vitro approaches, given that the mouse strain is easy to breed and sufficient numbers of 
brains can be obtained. The great advantage of purifying tubulin from a single mouse brain is 
that biological replicates can be introduced in the in-vitro approach; as multiple tubulin 
samples from individual mouse brains can be used side-by-side.  
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The most work-intense approach is the purification of tubulin from adherently growing cells. 
The great advantage of this approach is that it allows to generate virtually any type of 
posttranslationally modified tubulin, given the availability of a wide range of modifying 
enzymes53-60. We recommend to use this method after only an assay has duly be established 
using brain tubulin or non-modified tubulin from cells grown in spinner cultures, which are 
easier to produce.  
Our protocol thus could allow research teams that perform in vitro reconstitution assays to 
fully replace brain tubulin by Hela S3 tubulin, a tubulin free of PTMs and exotic tubulin 
isotypes, on a daily basis. By expanding the protocol to the purification of tubulin modified 
with a variety of PTMs, their role can now be directly studied in vitro, which was so far 
virtually impossible. The proof of principle has been provided by the direct comparison of 
fully tyrosinated and fully detyrosinated Hela S3 tubulin in single-molecule motility assays 
and force measurements for the kinetochore kinesin CENP-E20, binding assays of neuronal 
kinesin motors22, or in transport assays with purified neuronal transport vesicles21. These 
examples demonstrate that PTM-free tubulin obtained by our protocol could be a valid 
replacement of the so-far used brain tubulin in all currently used in vitro reconstitution assays.  
  
 43
ACKNOWLEDGEMENTS 
We thank all members of the Janke lab for help during the establishment of the protocol. We 
would like to thank the animal facility of the Institut Curie for help with mouse breeding and 
care. This work has received support under the program “Investissements d’Avenir” launched 
by the French Government and implemented by ANR with the references ANR-10-LBX-
0038, ANR-10-IDEX-0001-02 PSL. The work of CJ was supported by the Institut Curie, the 
French National Research Agency (ANR) award ANR-12-BSV2-0007, the Institut National 
du Cancer (INCA) grants 2013-1-PL BIO-02-ICR-1 and 2014-PL BIO-11-ICR-1, the 
Fondation pour la Recherche Medicale (FRM) grant DEQ20170336756, and the CEFIPRA 
research project 5703-1. MMM is supported by the EMBO short-term fellowship ASTF 148-
2015 and by the Fondation Vaincre Alzheimer grant FR-16055p. JS was supported by the 
FRM fellowship SPF20120523942, and the EMBO ALTF 638-2010 and EMBO ASTF 445-
2012. SB was supported by the FRM grant FDT201805005465. JAS was supported by the 
European Union’s Horizon 2020 research and innovation programme under the Marie 
Skłodowska-Curie grant agreement No 675737. The antibody 12G10, developed by J. Frankel 
and M. Nelson, was obtained from the Developmental Studies Hybridoma Bank developed 
under the auspices of the NICHD and maintained by the University of Iowa.  
 
AUTHOR CONTRIBUTION 
J.S. and M.M.M. established, with the help of G.L. and A.G., the spinner cultures for various 
cell lines and adapted the tubulin purification protocol to spinner-grown cells. S.B. and 
M.M.M. established the tubulin prep from adherent cells. S.B., M.M.M. and J.A.S. 
contributed to improving the protocol of the tubulin prep from large cell quantities. M.M.M. 
established the tubulin prep protocol from single mouse brains. M.M.M. and C.J. supervised 
the development of this method and wrote the manuscript. All the authors contributed to 
corrections of the text and figures.  
 
COMPETING FINANCIAL INTEREST STATEMENT 
The authors declare that they have no competing financial interests. 
  
 44
DATA AVAILABILITY STATEMENT 
The data that support the findings of this study are available from the corresponding author 
upon reasonable request. 
  
 45
Figure 1: Flow scheme of the tubulin purification protocol. 
Different steps of the tubulin purification are schematically depicted. After the lysis and lysate 
clarification (Steps 2-4), the first polymerisation is carried out in low-molarity conditions 
(low-molarity pol; polymerisation 1, Steps 7-10). Microtubules are then pelleted, 
depolymerised, and soluble tubulin is clarified (depolymerisation 1, Steps 12-15). Soluble 
tubulin is then subjected to a high-molarity polymerisation, excluding the MAPs 
(polymerisation and depolymerisation 2, Steps 19-28). After polymerisation 2 it is possible to 
purify microtubule-associated proteins (MAPs). Tubulin can be further subjected to a third, 
low-molarity polymerisation followed by depolymerisation (polymerisation and 
depolymerisation 3, Steps 31-39), in order to completely remove the high-molarity buffer 
from polymerisation 2. The temperature of the step is indicated by the background colour. 
The nature of the discarded fraction is indicated as well as the possible pause points (optional 
freezing steps) and additional treatment. Approximative timing of the procedure is also given. 
 
Figure 2: Growing Hela S3 and HEK-293 cells in spinner cultures for tubulin 
purification. 
a. Overview of the spinner culture (step 1A): Cells are first grown on 15-cm plates to 80-90% 
confluence. They are then detached, thoroughly dissociated and inoculated in spinner bottles. 
The bottles are then incubated for 7 days in a cell culture incubator equipped with a rotating 
table. Optionally, cells can be treated one or two days before being harvested and proceeded 
for the tubulin purification (see Fig. 3). b. Close-up view of the spinners with medium only, 
just after inoculation (Step 1A(xi)), and after 7 days of culture of Hela S3 and HEK-293 cells 
(Step 1A(xii)). Note the homogeneous aspect of Hela S3 culture after 7 days, in contrast to the 
aggregates formed by HEK-293 cells. These cell aggregates are visible to naked eye. c. 
Representative images of Hela S3 and HEK-293 cells grown on plastic dishes (Step 1A(iv)), 
after spinner inoculation (Step 1A(xi)) and after 7 days in the spinners (Step 1A(xii)). Note 
that HEK-293 form cell aggregates up to several hundred µm in diameter. Scale bar: 50 µm. 
 
Figure 3: Tubulin purification from cells cultured in spinner bottles. 
a. Harvesting the cells (Steps 1A(xiv-xx)): Cells grown for 7 days in spinners are transferred 
to 1-l bottles and pelleted. Cells are re-suspended in PBS and transferred to a 50-ml conical 
tube and pelleted again. The pellet volume is recorded and cells are re-suspended in the same 
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volume of lysis buffer. b. The set-up used to lyse the cells: while Hela S3 cells are broken 
using a French press, HEK-293 cells are lysed by repeated passages through a p1000 tip 
tightly fitted on a 5-ml pipette (step 2A(i)). Both HEK-239 and Hela S3 cell lysates are then 
repeatedly passed through a p200 tip fitted on a p1000 tip on a p1000 pipette (steps 2A(ii) and 
2B(ii)). c. Representative images of Hela S3 and HEK-293 cells before and after lysis (steps 
2A and 2B). Note the presence of cell debris (purple crosses) in the lysates. Scale bar 50 µm. 
d. Images of the purification process (steps 3-28): After ultracentrifugation, cleared cell 
lysates contains a white floating layer (→). If this material is transferred together with the 
supernatant, making it turbid (*), it can be efficiently clarified in a step of low-speed 
centrifugation. The first-polymerisation microtubule pellet has a white and uneven appearance 
(#). Following the first depolymerisation and cold centrifugation, a pellet is well visible ($). 
The second polymerisation gives a clear and transparent pellet (€). The second 
depolymerisation produces a very small, hardly visible microtubule pellet (>>). 
 
Figure 4: Analyses of purified tubulin obtained from cell lines and mice brains. 
a. Coomassie-stained acrylamide gel with samples of different steps throughout the tubulin 
purification procedure. Note the enrichment of α- and β-tubulin throughout the procedure 
until its pure fraction (P4), and the tubulin-free fraction containing only MAPs (SN4). 
Tubulin from P4 can be further submitted to depolymerisation – polymerisation cycles (not 
shown). b. Generation of totally tyrosinated and totally detyrosinated Hela S3 tubulin. 
Immunoblot analysis of purified pig brain, untreated Hela S3 tubulin, and Hela S3 tubulin 
treated with carboxypeptidase A (+CPA). While brain tubulin is a mixture of tyrosinated and 
detyrosinated tubulin, untreated Hela S3 tubulin is entirely tyrosinated. This tyrosinated 
tubulin is fully converted to detyrosinated tubulin by using CPA. c. Different patterns of 
tubulin polyglutamylation following overexpression of TTLL5 or TTLL7. Immunoblot 
analysis of tubulin purified from HEK-293 cells overexpressing polyglutamylases TTLL5 or 
TTLL7. Note that while HEK-293 cells have very low levels of tubulin polyglutamylation, 
TTLL5 overexpression leads to polyglutamylation of both α- and β-tubulin, while TTLL7 
modifies only β-tubulin. d. Modification levels of tubulin purified from brains of wild-type, 
atat1-/- and ttll1-/- mice. Knockout of aTAT1, the tubulin acetyltransferase59,60, leads to the 
loss of acetylation of lysine K40 of α-tubulin. TTLL1, main brain glutamylase53, leads to a 
reduction of tubulin polyglutamylation. Note that a special acrylamide gels have been used, 
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which allow to separate α- and β-tubulin bands that usually co-migrate slightly above 
50 kDa50. In b, c and d equal levels of total tubulin were verified with 12G10, an anti-α-
tubulin antibody. Experimental procedures involving animals were specifically approved by 
the ethics committee of the Institut Curie CEEA-IC #118 (authorization no. 04395.03 given 
by National Authority) in compliance with the international guidelines. 
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